Well I guess we can allways sue them... I mean it was in the tender for our machine
-
-
I guess that is how the cookie crumbles, eh? You should have gone Ion. I have no problem getting the sequences for simple things like this for my PGM. They have it all in their "closed community" or you can harass their support guys who end up sharing it with you.
Good luck!Comment
-
The new letter, near as I can tell (and please correct me if I am missing something) does have the complete structure/sequence of the Nextera v2 "adapters" and the approximate positions of the sequencing primers.Originally posted by aleferna View Post
So, is that enough to create your own adapters for a custom protocol? Seems like it should be.
I do share your apparent anger with Illumina for the way they are handling this. But seems like nearly everything is spelled out now?
--
PhillipComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment